(877) 330-2919
Have multiple conditions? Click here
Select your condition
Tell us what's ailing you or use the guide to select multiple conditions
Choose your location
Enter your Zip Code into the guide or click on a state to find trials near you
Speak to an expert
The quickest way to get started! Get instantly connected to the right trial

Clinical Trials in Rhode Island (RI) | Rhode Island Clinical Drug Trials & Studies

You are viewing Clinical Trials In Rhode Island
Have multiple conditions? Click here

Showing 1-100 of 430
There are 430 trials in Rhode Island
Name City State Zip
Phase II Avastin Trial for Stage IIIB/IV NSCLC Woonsocket RI 02895
AIGISRx Envelope for Prevention of Infection Following Replacement With a Cardiac Resynchronization Therapy Device (CRT) Woonsocket RI 02895
AIGISRx Envelope for Prevention of Infection Following Replacement With an Implantable Cardioverter-Defibrillator (ICD) Woonsocket RI 02895
Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer Warwick RI 02886
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Warwick RI 02886
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery Warwick RI 02886
Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer Warwick RI 02886
Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed By Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery Warwick RI 02886
Consortium On Risk for Early-onset Parkinson's Disease (CORE PD) Warwick RI 02886
Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder Warwick RI 02886
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL) Warwick RI 02886
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects Warwick RI 02886
Study to Evaluate the Long-Term Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) in Patients Who Require Opioid Treatment for an Extended Period of Time Warwick RI 02886
Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) for Relief of Moderate to Severe Pain in Patients With Osteoarthritis or Low Back Pain Who Require Opioid Treatment for an Extended Period of Time Warwick RI 02886
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy Wakefield RI 02879
18 Month Follow-up Visit of High Risk Infants Providence RI 02905
Generic Database of Very Low Birth Weight Infants Providence RI 02905
Carboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel, Carboplatin, and Paclitaxel in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer) Providence RI 02905
Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer Providence RI 02905
Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer Providence RI 02905
Correlation of the Chemoresponse Assay With PFS in Patients With Recurrent Epithelial Ovarian, Peritoneal, or Fallopian Tube Cancer Providence RI 02905
Conservative Management With Isolated Sentinel Lymph Node Biopsy in Vulvar Cancer Patients. Providence RI 02905
Fludeoxyglucose F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer Providence RI 02905
Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer Providence RI 02905
Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer Providence RI 02905
Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer Providence RI 02905
Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer Providence RI 02905
Protective Effects of Delayed Cord Clamping in Very Low Birth Weight (VLBW) Infants Providence RI 02905
Maternal Hypothyroidism in Pregnancy Providence RI 02905
A Study of Ixabepilone as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer Providence RI 02905
Studying Biomarkers in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells Providence RI 02905
Panitumumab and Gemcitabine in Relapsed Ovarian Cancer Providence RI 02905
A Trial of 2% Lidocaine Gel for Intrauterine Device (IUD) Insertion Providence RI 02905
Collecting Tumor Samples From Patients With Gynecological Tumors Providence RI 02905
Tumor Marker YKL-40 in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing Chemotherapy Providence RI 02905
The National Standard for Normal Fetal Growth Providence RI 02905
Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer Providence RI 02905
Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Providence RI 02905
Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer Providence RI 02905
Symptom Management in Patients With Recurrent or Persistent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Providence RI 02905
TIPPS: Thrombophilia in Pregnancy Prophylaxis Study Providence RI 02905
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker Providence RI 02905
Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer Providence RI 02905
Sunitinib Malate in Treating Patients With Persistent or Recurrent Clear Cell Ovarian Cancer Providence RI 02905
Lysophosphatidic Acid Assay in Patients With Ovarian Cancer or Who Are at Risk for Ovarian Cancer Providence RI 02905
Carboplatin, Paclitaxel, Bevacizumab, and ABT-888 in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Providence RI 02905
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer Providence RI 02905
Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma Providence RI 02905
Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis Providence RI 02905
Multi-dose Pharmacokinetics and Dose Ranging of Inositol in Premature Infants (INS-2) Providence RI 02905
AMG 102 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Providence RI 02905
Noninvasive Screening for Fetal Aneuploidy: Assay Development & Optimization in Affected Pregnancies Providence RI 02905
Intraperitoneal Bortezomib and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Providence RI 02905
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy Providence RI 02905
Prophylactic Phenobarbital After Neonatal Seizures Providence RI 02905
Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical Cancer Providence RI 02905
Radiation Therapy With or Without Chemotherapy in Patients With Stage I or Stage II Cervical Cancer Who Previously Underwent Surgery Providence RI 02905
A Prospective, Noninterventional Follow-Up Study of Children Aged 23 to 25 Months, Born to Mothers Who Received Hydroxyprogesterone Caproate Injection, 250 mg/mL, or Vehicle for Prevention of Preterm Birth Providence RI 02905
Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer Providence RI 02905
Ixabepilone in Treating Patients With Recurrent or Persistent Uterine Cancer Providence RI 02905
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE) Providence RI 02905
Vitamin E for Extremely Preterm Infants Providence RI 02905
Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Clear Cell Ovarian Cancer Providence RI 02905
Consent for Use of Stored Patient Specimens for Future Testing Providence RI 02906
Maintaining Exercise After Cardiac Rehabilitation Providence RI 02906
Safety and Efficacy Study of ICXP007 With Compression Bandaging for the Treatment of Non-Infected Venous Leg Ulcers Providence RI 02908
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Providence RI 02908
Trial of 2nd Generation Anti-CEA Designer T Cells in Gastric Cancer Providence RI 02908
Five Year Adjuvant Imatinib Mesylate (Gleevec®) in Gastrointestinal Stromal Tumor (GIST) Providence RI 02908
Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery Providence RI 02908
Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer Providence RI 02908
Immunotherapy Study for Surgically Resected Pancreatic Cancer Providence RI 02908
Laboratory-Treated Autologous Lymphocytes, Aldesleukin, and Sargramostim (GM-CSF) in Treating Patients With Advanced Solid Tumors Providence RI 02908
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF) Providence RI
The TMC125-C214 Study Provides Early Access to TMC125 for HIV-1 Infected Patients Who Have Failed Multiple Antiretroviral Regimens and Will Also Gather Information on the Long-term Safety and Tolerability of TMC125 Combined With Other Antiretroviral Drugs. Providence RI
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry Providence RI
Post-marketing, Observational Study of HUMIRA® (Adalimumab) in Patients With Chronic Plaque Psoriasis (Ps) Providence RI
A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) With or Without Ribavirin in Patients With Chronic Hepatitis C Who Have Participated in Previous Roche or Roche Partner Protocols. Providence RI
A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH) Providence RI
Study of Adacel® Vaccine Administered to Persons 10 Years of Age Providence RI
A Study on The Combination of RO5024048 And Ritonavir-Boosted Danoprevir With And Without Copegus (Ribavirin) in Interferon-Naïve Patients With Chronic Hepatitis C Genotype 1 (INFORM-SVR) Providence RI
A Study to Evaluate the Efficacy and Safety of IV Peramivir in Addition to Standard of Care Compared to Standard of Care Alone in Adults and Adolescents Who Are Hospitalized Due to Influenza Providence RI
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome Providence RI
Study of XL147 in Advanced or Recurrent Endometrial Cancer Providence RI
A Study of Intravenous Tamiflu (Oseltamivir) in Children With Influenza Providence RI
A Study With Aleglitazar in Patients With a Recent Acute Coronary Syndrome and Type 2 Diabetes Mellitus Providence RI
A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza Providence RI
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease Providence RI
Febuxostat Versus Allopurinol or Placebo in Subjects With Hyperuricosuria and Calcium Oxalate Stones Providence RI
Effect of Febuxostat on Joint Damage in Hyperuricemic Subjects With Early Gout Providence RI
A Safety and Efficacy Study of the Combination of VX-222 and Telaprevir in Treatment-Naïve Subjects With Genotype 1 Chronic Hepatitis C Virus Infection Providence RI
Cardiovascular Safety of Febuxostat and Allopurinol in Patients With Gout and Cardiovascular Comorbidities Providence RI
Efficacy and Safety of Gadobutrol 1.0 Molar (Gadovist) for Breast Magnetic Resonance Imaging (MRI) Providence RI
The CANTATA-D Trial (CANagliflozin Treatment and Trial Analysis - DPP-4 Inhibitor Comparator Trial) Providence RI
A Study of Trastuzumab-DM1 Plus Pertuzumab Versus Trastuzumab [Herceptin] Plus a Taxane in Patients With Metastatic Breast Cancer (MARIANNE) Providence RI
Study of Palifosfamide-tris in Combination With Doxorubicin in Patients With Front-line Metastatic Soft Tissue Sarcoma Providence RI
An Observational Study on Long-Term Persistence of Resistant Mutations And Durability of Sustained Virological Response in Patients With Chronic Hepatitis C Treated With Direct Acting Antiviral (DAA)- Containing Regimens Providence RI
A Study of the Safety and Efficacy of Pimavanserin in Patients With Parkinson's Disease Psychosis Providence RI
Efficacy and Safety of Lu AA21004 in Adults With Major Depressive Disorder Providence RI
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer Providence RI
View Clinical Trial Facilities in Rhode Island

Showing 1-100 of 430
browse trials by condition
helpful resources
share this page


Alabama - Alaska - Arizona - Arkansas - California - Colorado - Connecticut - Delaware - Washington DC - Florida - Georgia - Hawaii - Idaho - Illinois - Indiana - Iowa - Kansas - Kentucky - Louisiana - Maine - Maryland - Massachusetts - Michigan - Minnesota - Mississippi - Missouri - Montana - Nebraska - Nevada - New Hampshire - New Jersey - New Mexico - New York - North Carolina - North Dakota - Ohio - Oklahoma - Oregon - Pennsylvania - Rhode Island - South Carolina - South Dakota - Tennessee - Texas - Utah - Vermont - Virginia - Washington - West Virginia - Wisconsin - Wyoming
Featured Locations: Anaheim - Atlanta - Birmingham - Cleveland - DeLand - Jacksonville - Miami - Oklahoma City
About Us | Contact Us | Privacy Policy | Terms of Service | Sitemap
For Sponsors: Promote Your Study | For Research Sites: Promote Your Site

Copyright 2012 Clinical Trials Institute, LLC | All Rights Reserved
Fill out the information below to find the right trial
Step 1: Contact Information
Step 2: Tell Us About Yourself



Do You Smoke
Can you stay overnight?
*Some trials require overnight observation
Step 3: Find Trials for the Following Conditions (choose all that apply)
  • Cardiology / Vascular Diseases






  • Dental / Maxillofacial Surgery

  • Dermatology / Plastic Surgery






  • Endocrinology





  • Gastroenterology








  • Hematology




  • Immunology / Infectious Diseases








  • Musculoskeletal




  • Nephrology / Urology






  • Neurology





  • Oncology












  • Ophthalmology

  • Orthopedics / Podiatry



  • Other



  • Otolaryngology


  • Pharmacology / Toxicology


  • Psychiatry / Psychology






  • Pulmonary / Respiratory Diseases








  • Reproductive






  • Rheumatology








Yes, please send me updates about the latest trials in my area

Thanks for submitting your information!
You will be contacted by one of our Clinical Trials Specialists to help guide you through the process of finding the right trial for you!
Based on your responses, we have a few additional questions (optional):
Login
Forgot password?
Enter your email and we will resend your password
Register
Change Password